With both CES and the JP Morgan conference on the horizon, there’s bound to be plenty to discuss. But before we dive into conference week, let’s delve into a topic that dominated week one of 2024: Eli Lilly’s recent venture, LillyDirect. In today’s Inner Circle brief, we’ll dissect Lilly’s foray into the DTC domain, its significance, and potential impacts on women’s health and the femtech ecosystem.
Lilly’s Entry into Direct-to-Consumer Healthcare
Last week, just days before the JP Morgan conference, Lilly, a renowned name in the pharmaceutical industry, announced the launch of LillyDirect, its new End-to-End Digital Healthcare Experience.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.
